Agios Pharmaceuticals AGIO Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's common stock, shares authorized (in shares)?
- Agios Pharmaceuticals (AGIO) reported common stock, shares authorized (in shares) of $125M in Q1 2026.
- How has Agios Pharmaceuticals's common stock, shares authorized (in shares) changed year-over-year?
- Agios Pharmaceuticals's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $125M to $125M.
- What is the long-term trend for Agios Pharmaceuticals's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $125M to $125M.